Applied Therapeutics trading resumes

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See today’s best-performing stocks on TipRanks >>

Read More on APLT:

• Applied Therapeutics’ NDA for govorestat receives negative response from FDA
• Applied Therapeutics trading halted, news pending
• Applied Therapeutics price target raised to $13 from $11 at Citi
• RBC says if Applied’s govorestat were to be approved, would likely hear today
• Applied Therapeutics Advances with Govorestat Approvals